PPARG and metabolic dysfunction-associated steatotic liver disease: Research showed that the methylation levels of peroxisome proliferator-activated receptor γ (PPARγ) in plasma-free DNA could differentiate the severity of NAFLD and was a potential noninvasive biomarker for NAFLD [84].